A Review of the Treatment of Type 2 Diabetes in Children
Authors:
- 1 January 2015
- journal article
- review article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 20 (1) , 4-16
Abstract
The incidence of type 2 diabetes and obesity in children and adolescents has risen at staggering rates. Studies have shown that treating type 2 diabetes with oral medications in children may be more difficult than treating in adults. Compounding this problem is the fact that most of the medications available for treating type 2 diabetes have not been studied in children. Recently, the American Diabetes Association and the Pediatric Endocrine Society have collaborated to create a guideline for the treatment of type 2 diabetes in children. Similar to the treatment of adults with type 2 diabetes, metformin remains the mainstay of therapy along with diet and exercise. Adjunctive therapy should be based on the limited clinical evidence available as well as on patient preference. In order to avoid detrimental microvascular and macrovascular complications, patients, clinicians, and family members should work together to ensure adequate treatment of type 2 diabetes in children.Keywords
This publication has 54 references indexed in Scilit:
- Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese AdultsJAMA, 2012
- A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 DiabetesNew England Journal of Medicine, 2012
- Exenatide as a Weight‐Loss Therapy in Extreme Pediatric Obesity: A Randomized, Controlled Pilot StudyObesity, 2012
- Type 2 diabetes across generations: from pathophysiology to prevention and managementThe Lancet, 2011
- The Effect of Oral Antidiabetic Agents on A1C LevelsDiabetes Care, 2010
- The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 DiabetesDiabetes Care, 2010
- Childhood Obesity, Other Cardiovascular Risk Factors, and Premature DeathNew England Journal of Medicine, 2010
- Twenty-Four-Hour Simultaneous Subcutaneous Basal-Bolus Administration of Insulin and Amylin in Adolescents with Type 1 Diabetes Decreases Postprandial HyperglycemiaThe Journal of Clinical Endocrinology & Metabolism, 2009
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes, 2009
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysisCanadian Medical Association Journal, 2009